Arcturus Therapeutics Holdings Inc (ARCT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $240.96M
Last updated: Nov 17, 2026 at 4:34 PM ET
Arcturus Therapeutics Holdings Inc (ARCT) Stock Chart
Arcturus Therapeutics Holdings (ARCT) has a latest price of $7.97 on Nov 17, 2026, 55.6% below its 52-week high of $17.96. Its price rose 9.6% over the past 12 months. The month-end price fell 17.9% over the 10 years through Oct 2026, a compound annual decline of 2.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $91.76 in Nov 2020 and its lowest $4.53 in Dec 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ARCT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ARCT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 22.5%, and over 6 months it rose 19.1%. The month-end price fell 42.3% over the 3 years through Oct 2026, a compound annual decline of 16.7%.
| Period | Change |
|---|---|
| 1 month | -23.5% |
| 3 months | -22.5% |
| 6 months | +19.1% |
| 12 months | +9.6% |
| 12 months, with dividends | +9.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -42.3% | -16.7% |
| 5 years | -75.5% | -24.5% |
| 10 years | -17.9% | -2.0% |
Price by Year
Its best calendar year was 2020, when the price rose 299.1%, and its weakest was 2025, when it fell 63.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $11.03 | +79.9% |
| 2025 | $6.13 | -63.9% |
| 2024 | $16.97 | -46.2% |
| 2023 | $31.53 | +85.9% |
| 2022 | $16.96 | -54.2% |
| 2021 | $37.01 | -14.7% |
| 2020 | $43.38 | +299.1% |
| 2019 | $10.87 | +140.0% |
| 2018 | $4.53 | -43.0% |
| 2017 | $7.95 | -45.9% |
Trading Range
The price is 34.3% below its 50-day average of $12.13 and 12.5% below its 200-day average of $9.11.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.97 | |
| 52-week high | $17.96 | -55.6% |
| 52-week low | $5.50 | +44.9% |
| 50-day average | $12.13 | -34.3% |
| 200-day average | $9.11 | -12.5% |
Price Risk
Over 3 years, its largest fall from a peak was 87.5%.
| Measure | Value |
|---|---|
| 1-year beta | 2.07 |
| Largest fall, 1 year | -52.9% |
| Largest fall, 3 years | -87.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ARCT
What is ARCT's 1-year price change?
Arcturus Therapeutics Holdings's price rose 9.6% over the past 12 months. With dividends included, the 12-month total return was 9.6%.
What is ARCT's 5-year price change?
Arcturus Therapeutics Holdings's month-end price fell 75.5% over the 5 years through Oct 2026, a compound annual decline of 24.5%. These figures leave out dividends.
What is ARCT's 52-week high and low?
Arcturus Therapeutics Holdings's 52-week high is $17.96 and its 52-week low is $5.50. Its latest price of $7.97 on Nov 17, 2026 is 55.6% below the high.
What is ARCT's beta?
Arcturus Therapeutics Holdings's 1-year beta against the S&P 500 is 2.07, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 52.9%.
Is the ARCT chart free?
Yes. Advanced Charting for ARCT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ARCT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors